Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,869 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Are there enough radiation oncologists to lead the new Spanish radiotherapy?
Rodríguez A, Arenas M, Lara PC, López-Torrecilla J, Algara M, Conde A, Pérez-Montero H, Muñoz JL, Peleteiro P, Pérez-Calatayud MJ, Contreras J, Ferrer C; Spanish Society of Oncology and Radiotherapy (SEOR) Analysis Group. Rodríguez A, et al. Clin Transl Oncol. 2019 Dec;21(12):1663-1672. doi: 10.1007/s12094-019-02095-x. Epub 2019 Apr 3. Clin Transl Oncol. 2019. PMID: 30941701
Quality indicators in radiation oncology: proposal of the Spanish Society of Radiation Oncology (SEOR) for a continuous improvement of the quality of care in oncology.
López Torrecilla J, Marín I Borràs S, Ruiz-Alonso A, Jaen Olasolo J, Vázquez de la Torre ML, Bóveda Carro E, Rodríguez A, Ignacio García E, Caballero Martínez F, Campos Lucas FJ, Lara Jiménez PC, Martínez JC, Ferrer Albiach C. López Torrecilla J, et al. Among authors: rodriguez a. Clin Transl Oncol. 2019 Apr;21(4):519-533. doi: 10.1007/s12094-018-1943-z. Epub 2018 Oct 11. Clin Transl Oncol. 2019. PMID: 30311145 Free article.
Demand for radiotherapy in Spain.
Rodríguez A, Borrás JM, López-Torrecilla J, Algara M, Palacios-Eito A, Gómez-Caamaño A, Olay L, Lara PC. Rodríguez A, et al. Clin Transl Oncol. 2017 Feb;19(2):204-210. doi: 10.1007/s12094-016-1525-x. Epub 2016 Aug 4. Clin Transl Oncol. 2017. PMID: 27492014 Review.
Infrastructure and equipment for radiation oncology in the Spanish National Health System: analysis of external beam radiotherapy 2015-2020.
Rodríguez A, Algara M, Monge D, López-Torrecilla J, Caballero F, Morera R, Escó R, Pérez-Montero H, Ferrer C, Lara PC; Spanish Society of Oncology and Radiotherapy (SEOR) Analysis Group. Rodríguez A, et al. Clin Transl Oncol. 2018 Mar;20(3):402-410. doi: 10.1007/s12094-017-1727-x. Epub 2017 Aug 3. Clin Transl Oncol. 2018. PMID: 28776310
Recent developments in radiotherapy for small-cell lung cancer: a review by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
Rodriguez de Dios N, Calvo P, Rico M, Martín M, Couñago F, Sotoca A, Taboada B, Rodríguez A. Rodriguez de Dios N, et al. Among authors: rodriguez a. Clin Transl Oncol. 2017 Oct;19(10):1183-1192. doi: 10.1007/s12094-017-1667-5. Epub 2017 Apr 26. Clin Transl Oncol. 2017. PMID: 28447257 Review.
Targeted therapy combined with radiotherapy in non-small-cell lung cancer: a review of the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
Couñago F, Rodríguez A, Calvo P, Luna J, Monroy JL, Taboada B, Díaz V, Rodríguez de Dios N. Couñago F, et al. Among authors: rodriguez a, rodriguez de dios n. Clin Transl Oncol. 2017 Jan;19(1):31-43. doi: 10.1007/s12094-016-1512-2. Epub 2016 Apr 22. Clin Transl Oncol. 2017. PMID: 27106020 Review.
A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM).
González A, Lluch A, Aba E, Albanell J, Antón A, Álvarez I, Ayala F, Barnadas A, Calvo L, Ciruelos E, Cortés J, de la Haba J, López-Vega JM, Martínez E, Muñoz M, Peláez I, Redondo A, Rodríguez Á, Rodríguez CA, Ruíz A, Llombart A. González A, et al. Among authors: rodriguez a, rodriguez ca. Clin Transl Oncol. 2017 May;19(5):616-624. doi: 10.1007/s12094-016-1571-4. Epub 2016 Nov 16. Clin Transl Oncol. 2017. PMID: 27853985 Review.
Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain.
Balañá C, Vaz MA, Lopez D, de la Peñas R, García-Bueno JM, Molina-Garrido MJ, Sepúlveda JM, Cano JM, Bugés C, Sanz SM, Arranz JL, Perez-Segura P, Rodriguez A, Martin JM, Benavides M, Gil M. Balañá C, et al. Among authors: rodriguez a. Clin Transl Oncol. 2014 Mar;16(3):273-9. doi: 10.1007/s12094-013-1068-3. Epub 2013 Jun 21. Clin Transl Oncol. 2014. PMID: 23793813
7,869 results